The Functional Roles of Exosomal Long Non-coding RNAs in Cancer

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2019 Jan 27

PMID 30683984

Citations 72

Authors

Man Wang

Li Zhou

Fei Yu

Yinfeng Zhang

Peifeng Li

Kun Wang

Affiliations

Soon will be listed here.

Abstract

Exosomes are extracellular membranous vesicles that are secreted by various cell types. Exosomes have become indispensable facilitators in the exchange of information between cells. More importantly, exosomes perform a crucial role in a variety of diseases including cancers. Long non-coding RNAs (lncRNAs) are over 200 nucleotides long transcripts that exhibit no or limited protein-coding potentials. LncRNAs are an emerging group of regulatory RNAs and can be selectively packaged into exosomes. Exosomal lncRNAs play a central role in carcinogenesis and cancer progression by modulating tumor growth, metastasis, angiogenesis and chemoresistance. Moreover, exosomal lncRNAs function as messengers in cell-to-cell communication, and thus remodel the tumor microenvironment. Their function relevance in cancer biology hints at the possibility of employing exosomal lncRNAs as promising, non-invasive biomarkers for further cancer therapy. In this review, we provide an overview of current research on the functional roles of exosomal lncRNAs in cancer and discuss their potential clinical applications as diagnostic biomarkers and therapeutic targets for cancers.

Citing Articles

Macrophage-derived lncRNAs in cancer: regulators of tumor progression and therapeutic targets.

Suliman M, Saleh R, Chandra M, Rasool K, Jabir M, Jawad S Med Oncol. 2025; 42(4):91.

PMID: 40048034 DOI: 10.1007/s12032-025-02643-2.

Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma.

Jin P, Bai X IBRO Neurosci Rep. 2025; 18:323-337.

PMID: 40034544 PMC: 11872630. DOI: 10.1016/j.ibneur.2025.01.015.

Potential Use of Exosomal Non-Coding MicroRNAs in Leukemia Therapy: A Systematic Review.

Gil-Kulik P, Kluz N, Przywara D, Petniak A, Wasilewska M, Fraczek-Chudzik N Cancers (Basel). 2024; 16(23).

PMID: 39682135 PMC: 11639955. DOI: 10.3390/cancers16233948.

Exosomal SLC16A1-AS1-induced M2 macrophages polarization facilitates hepatocellular carcinoma progression.

Hu Y, Li Y, Xiong H, Zhang Y, Wang F, Zhuo W Int J Biol Sci. 2024; 20(11):4341-4363.

PMID: 39247822 PMC: 11379075. DOI: 10.7150/ijbs.94440.

Tumor-associated exosomes in cancer progression and therapeutic targets.

Liu X, Wu F, Pan W, Liu G, Zhang H, Yan D MedComm (2020). 2024; 5(9):e709.

PMID: 39247621 PMC: 11380050. DOI: 10.1002/mco2.709.

References

Li B, Xu H, Han H, Song S, Zhang X, Ouyang L . Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis. Oncogene. 2018; 37(41):5508-5519. DOI: 10.1038/s41388-018-0359-0. View

Sukowati C, Anfuso B, Torre G, Francalanci P, Croce L, Tiribelli C . The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study. PLoS One. 2013; 8(10):e76830. PMC: 3792890. DOI: 10.1371/journal.pone.0076830. View

Wang S, Li X, Zhu R, Han Q, Zhao R . Lung cancer exosomes initiate global long non-coding RNA changes in mesenchymal stem cells. Int J Oncol. 2015; 48(2):681-9. DOI: 10.3892/ijo.2015.3272. View

Roychoudhury P, Chaudhuri K . Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma. Br J Cancer. 2007; 97(4):574-5. PMC: 2360341. DOI: 10.1038/sj.bjc.6603911. View

Wang Y, Ji J, Wang B, Chen H, Yang Z, Wang K . Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer. Cell Physiol Biochem. 2018; 46(2):532-545. DOI: 10.1159/000488620. View

Takahashi K, Yan I, Wood J, Haga H, Patel T . Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy. Mol Cancer Res. 2014; 12(10):1377-87. PMC: 4201956. DOI: 10.1158/1541-7786.MCR-13-0636. View

Tomasetti M, Lee W, Santarelli L, Neuzil J . Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy. Exp Mol Med. 2017; 49(1):e285. PMC: 5291842. DOI: 10.1038/emm.2016.153. View

Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

Zhou R, Chen K, Zhang J, Xiao B, Huang Z, Ju C . The decade of exosomal long RNA species: an emerging cancer antagonist. Mol Cancer. 2018; 17(1):75. PMC: 5861621. DOI: 10.1186/s12943-018-0823-z. View

10.

Santangelo L, Giurato G, Cicchini C, Montaldo C, Mancone C, Tarallo R . The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting. Cell Rep. 2016; 17(3):799-808. DOI: 10.1016/j.celrep.2016.09.031. View

11.

Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

12.

Rossi M, Battafarano G, DAgostini M, Del Fattore A . The Role of Extracellular Vesicles in Bone Metastasis. Int J Mol Sci. 2018; 19(4). PMC: 5979436. DOI: 10.3390/ijms19041136. View

13.

Fatica A, Bozzoni I . Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2013; 15(1):7-21. DOI: 10.1038/nrg3606. View

14.

Ostrowski M, Carmo N, Krumeich S, Fanget I, Raposo G, Savina A . Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2009; 12(1):19-30. DOI: 10.1038/ncb2000. View

15.

Wu D, Deng S, Liu T, Han R, Zhang T, Xu Y . TGF-β-mediated exosomal lnc-MMP2-2 regulates migration and invasion of lung cancer cells to the vasculature by promoting MMP2 expression. Cancer Med. 2018; 7(10):5118-5129. PMC: 6198203. DOI: 10.1002/cam4.1758. View

16.

Zhang R, Xia Y, Wang Z, Zheng J, Chen Y, Li X . Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer. Biochem Biophys Res Commun. 2017; 490(2):406-414. DOI: 10.1016/j.bbrc.2017.06.055. View

17.

Marleau A, Chen C, Joyce J, Tullis R . Exosome removal as a therapeutic adjuvant in cancer. J Transl Med. 2012; 10:134. PMC: 3441244. DOI: 10.1186/1479-5876-10-134. View

18.

Kajimoto T, Okada T, Miya S, Zhang L, Nakamura S . Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes. Nat Commun. 2013; 4:2712. DOI: 10.1038/ncomms3712. View

19.

Li Z, Jiang P, Li J, Peng M, Zhao X, Zhang X . Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma. Oncogene. 2018; 37(28):3822-3838. DOI: 10.1038/s41388-018-0237-9. View

20.

Guo B, Bellingham S, Hill A . The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes. J Biol Chem. 2014; 290(6):3455-67. PMC: 4319014. DOI: 10.1074/jbc.M114.605253. View